card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

TMB Standardization by Alignment to Reference Standards

Phase 2 of the Friends of Cancer Research TMB Harmonization Project
Home / Insights / TMB Standardization by Alignment to Reference Standards

At ASCO 2019, we presented a poster with Friends of Cancer Research (FOCR), highlighting their Tumor Mutational Burden (TMB) Harmonization Project. The goal of this Project is to harmonize TMB estimates through alignment to reference standards in order to improve consistency across panels, for the sake of optimizing clinical application and facilitating integration of datasets generated from multiple assays.

In Phase 1 of the TMB Harmonization Project, a robust correlation was demonstrated between TMB estimated using targeted NGS gene panels and whole exome sequencing (WES) applied to TCGA data. These findings demonstrated the theoretical variability in TMB estimates across panels. Phase 2 employs sustainable TMB reference standard materials to assess the empirical variability in TMB estimates.

Complete the form below to access this scientific poster